MOUNTAIN VIEW - Smartlens, Inc., a clinical-stage ophthalmic technology company, has closed an oversubscribed $6.1 million Series A financing round to advance regulatory clearance for miLens, a novel, electronics-free, soft contact lens for monitoring diurnal intraocular pressure (IOP). The funding was led by Ambit Health Ventures, joined by Stanford University, Graphene Ventures, Sophia Innovation Capital, Plaisance Capital [...] The post Stanford Invests in Series A Round for Smartlens appeared first on Silicon Valley Daily.
Smartlens is a California-based medical device company that develops contact lens-based diurnal intraocular pressure monitoring devices for the healthcare industry.